The Monoclonal Antibodies (mAbs) Market has emerged as one of the fastest-growing segments in the global biopharmaceutical industry, transforming the treatment landscape for chronic and life-threatening diseases. From oncology to autoimmune disorders and infectious diseases, monoclonal antibodies have proven their potential in precision medicine—driving remarkable advancements...